Integra Lifesciences Holdings (IART) Misses Q1 EPS by 1c

Integra Lifesciences Holdings (NASDAQ: IART) reported Q1 EPS of $0.57, $0.01 worse than the analyst estimate of $0.58. Revenue for the quarter came in at $215.1 million versus the consensus estimate of $213.3 million.

For earnings history and earnings-related data on Integra Lifesciences Holdings (IART) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• MP Materials seen largely insulated after China export-control move
• Pfizer lung cancer drug misses survival goal in Phase 3 trial